GlassScriptPhysician profile
Colby P Atkins
NPI 1457358863
$11,990.17
in general payments reported to CMS, 2019-2025
29 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,544 · 2020: $2,436 · 2021: $2,840 · 2022: $970 · 2023: $1,574 · 2024: $733 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,200.11 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $4,540.13 | 2019-2025 | Artegraft Vascular Graft |
| Artegraft INC. | $1,979.20 | 2019-2020 | |
| Angiodynamics, INC. | $1,906.67 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $1,303.37 | 2020-2025 | Pristine, Lutonix Drug Coated Balloon, Venovo |
| Baxter Healthcare | $629.34 | 2019-2024 | Preveleak, Floseal |
| W. L. Gore & Associates, INC. | $434.59 | 2021-2024 | Gore Viabahn Endoprosthesis, Gore Propaten Vascular Graft, Gore Acuseal Vascular Graft |
| Medtronic, INC. | $174.06 | 2024 | Abre, Reliatack |
| Davol INC. | $140.33 | 2021 | |
| Stryker Corporation | $130.67 | 2025 | Inthrill Thrombectomy Catheter |
| Cagent Vascular INC | $130.14 | 2025 | Serrantor |
| Allergan, INC. | $109.75 | 2021 | |
| Inari Medical, INC. | $104.53 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $64.75 | 2024-2025 | Eluvia, Varithena Administration Pack |
| Venturemed Group, INC. | $59.22 | 2025 | Flex Vessel Prep System |
| Innocoll Pharmaceuticals Limited | $35.76 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $33.57 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Silk Road Medical, INC. | $26.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Astrazeneca Pharmaceuticals LP | $24.50 | 2021 | |
| Laminate Medical Technologies INC. | $23.80 | 2024 | Vasq External Support |
| Avita Medical Americas, LLC | $21.00 | 2025 | Cohealyx, Recell, Permeaderm |
| Surmodics, INC. | $18.50 | 2025 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Polynovo North America LLC | $16.69 | 2023 | |
| Pfizer INC. | $16.41 | 2021 | |
| Abbott Laboratories | $16.03 | 2024 | Jeti All In One Non-Sterile Kit |
| Cook Medical LLC | $14.05 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.65 | 2020 | |
| Convatec INC. | $12.46 | 2019 | |
| Covidien LP | $11.23 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colby Atkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.